The intravascular lithotripsy (IVL) market is rapidly evolving, marking one of the fastest-growing segments in the global peripheral vascular market. With a remarkable compound annual growth rate (CAGR) of 9.3% from 2020 to 2030, IVL presents significant opportunities for medical device companies. This post delves into the factors driving this growth, the advantages of IVL over traditional treatments, and the key players to watch in the coming years.

Why IVL is Gaining Traction

IVL technology is revolutionizing the treatment of peripheral artery disease (PAD), a condition characterized by narrowed arteries that reduce blood flow to the limbs. Traditionally, atherectomy has been a go-to treatment for PAD, involving the removal of plaque from blood vessels. However, IVL offers distinct advantages that are driving its adoption among physicians and patients alike.

1. Minimally Invasive Nature: IVL is a minimally invasive procedure that uses sonic pressure waves to fracture and modify calcified plaque within the artery walls. This reduces the need for more invasive surgical interventions, leading to shorter recovery times and less postoperative discomfort for patients.
2. Precise Plaque Modification: Unlike atherectomy, which physically removes plaque, IVL modifies the plaque, making it easier to compress and displace. This precision reduces the risk of complications such as vessel dissection or embolization, enhancing patient safety.
3. Favorable Clinical Outcomes: Clinical studies have demonstrated the effectiveness of IVL in improving vessel patency and reducing restenosis rates. These positive outcomes are contributing to the growing confidence in IVL as a reliable treatment option for PAD.

Market Dynamics and Opportunities

The IVL market is not only driven by technological advancements but also by the potential for revenue growth and portfolio diversification. The increasing prevalence of PAD, coupled with the aging global population, underscores the need for effective and innovative treatment solutions. As a result, many companies are entering the IVL market to address these unmet clinical needs.

Shockwave Medical currently stands as the sole contender in this market, offering the Peripheral Lithoplasty® Balloon Dilation Catheter for the Peripheral Lithoplasty® System, which received U.S. Food and Drug Administration (FDA) approval for peripheral usage in September 2016. The company has conducted trials like DISRUPT II, III, and below-the-knee (BTK) to affirm its efficacy in fem-pop and BTK arteries. Shockwave’s revenue mainly derives from the U.S., with a subsidiary in Germany. This innovative technology addresses current limitations by empowering clinicians to treat calcified plaques more effectively. Genesis MedTech, partnering with Shockwave, pursued National Medical Products Administration (NMPA) approval in China to market the Shockwave IVL System, aiming to bolster localized manufacturing and distribution.

Key Players to Watch

Several companies are making significant strides in the IVL market, each bringing unique innovations and securing strategic investments.

1. FastWave Medical: This company recently secured another IVL utility patent, positioning itself as a leader in IVL innovation. FastWave’s focus on advancing IVL technology is likely to yield cutting-edge solutions that will further drive market growth.
2. Vantis Vascular: Vantis Vascular has closed a $5 million SAFE financing round, signaling strong investor confidence in its IVL technology. With this capital infusion, Vantis is well-positioned to accelerate the development and commercialization of its IVL products.
3. Amplitude Vascular Systems: Although not as prominently featured in recent news, Amplitude Vascular Systems is another key player to watch. The company is poised to introduce novel IVL solutions that could significantly impact the market.

Looking Ahead: Global Intravascular Lithotripsy (IVL) Market

The IVL market’s growth trajectory shows no signs of slowing down. With continuous technological advancements and increasing clinical acceptance, IVL is set to become a mainstay in the treatment of PAD. Companies that invest in IVL technology now stand to benefit from substantial market opportunities and contribute to improving patient outcomes.

For those interested in exploring the IVL market further, iData Research’s “2024 Global Peripheral Vascular Market” report provides comprehensive insights into market trends, competitive analysis, and growth projections. Receive a complimentary executive summary of the above report by clicking on the button below.

FREE Sample Report

References

1. Vantis Vascular Raises $5M for Microcatheter IVL. PR Newswire. Retrieved from https://www.prnewswire.com/news-releases/vantis-vascular-secures-5-million-in-safe-financing-to-drive-innovation-in-vascular-interventions-302150782.html.
2. FastWave Medical Granted Fifth Utility Patent Reflecting Continuous Expansion of IVL IP Portfolio. Cision. Retrieved from ​​https://www.prweb.com/releases/fastwave-medical-granted-fifth-utility-patent-reflecting-continuous-expansion-of-ivl-ip-portfolio-302147352.html
3. Global Peripheral Vascular Market. iData Research. Retrieved from https://idataresearch.com/product/peripheral-vascular-devices-market/